Xanthine oxidase-IN-1

CAS No. 1071970-13-2

Xanthine oxidase-IN-1( —— )

Catalog No. M32805 CAS No. 1071970-13-2

Xanthine oxidase-IN-1 is an effective inhibitor of xanthine oxidase with an IC50 value of 6.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 517 Get Quote
5MG 781 Get Quote
10MG 1074 Get Quote
25MG 1555 Get Quote
50MG 2098 Get Quote
100MG 2673 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Xanthine oxidase-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Xanthine oxidase-IN-1 is an effective inhibitor of xanthine oxidase with an IC50 value of 6.5 nM.
  • Description
    Xanthine oxidase-IN-1 is a xanthine oxidase inhibitor extracted from patent WO2008126898A1, page 68, compound example 3, with an IC50 of 6.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Xanthine Oxidase (XAO)
  • Recptor
    Xanthine Oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1071970-13-2
  • Formula Weight
    314.24
  • Molecular Formula
    C16H8F2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(#N)C1=CN(C=2C1=CC(F)=C(F)C2)C3=CC(O)=C(C(O)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shimizu K, et al. Preparation of (aza)indole derivatives as xanthine oxidase inhibitors. WO2008126898 A1.
molnova catalog
related products
  • Xanthine oxidoreduct...

    Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.

  • Prudomestin

    Prudomestin is a natural product isolated from the heartwood of Prunus domestica, with xanthine oxidase (XO) inhibitory activity with IC50 of 6?μM.

  • Tigulixostat

    Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.